Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: YORE who wrote (433)	6/29/1998 6:22:00 PM
From: Anthony Wong	Respond to of 1722

YORE, the prescription no. according to the Dow Jones article: Pfizer says the number is small considering the 2.5 million prescriptions* written for the pill.* On WLA's P/E, if WLA is estimated to earn $1.40 in 1998 and $1.82 in 1999, then its P/E is lower than PFE's. However, if PFE meets the whisper no. as mentioned in your post, I'm sure the estimated earnings for 1999 would be revised. Much of the bullishness on WLA is based on Lipitor sales, which should benefit PFE as well. If I have the money, I'll buy a basket of other pharmaceutical co. stocks besides PFE (WLA, MRK, MTC).

To: YORE who wrote (433)	7/3/1998 6:07:00 PM
From: Sonki	Read Replies (1) \| Respond to of 1722

hot off the press. Calif. agency studying HMO's Viagra policy -- paper biz.yahoo.com here is parts of the above story.... Kaiser is one of the nation's largest HMOs with over 9.1 million member. Kaiser policy violates state law requiring HMOs to include treatment for medical necessities in covered benefits, the Times said. News of the investigation comes on the heels of a federal government order requiring states to pay for Viagra prescriptions under Medicaid programs.